Pharmaceutical Fronts (Jun 2023)

Preparation and Study on the Single-Crystal Structure of Flurbiprofen–Salicylamide Co-crystal

  • Jia-Wei Hou,
  • Yan-Qing Gong,
  • Gang Li,
  • Li-Wen Ma,
  • Hong-Juan Pan,
  • Han-Bin Shan,
  • Jia-Liang Zhong

DOI
https://doi.org/10.1055/s-0043-1769006
Journal volume & issue
Vol. 05, no. 02
pp. e101 – e108

Abstract

Read online

Co-crystals can improve the physicochemical properties of pharmaceutical active ingredients, and thus have great potential in improving drug performance. Some studies have obtained the powder spectrum of the co-crystal of flurbiprofen (FBP) and salicylamide (2-OHBZA) but have not obtained a single-crystal structure. In this study, co-crystals of FBP-2-OHBZA with a molar ratio of 1:1 were obtained by slow evaporation using ethyl acetate and tetrahydrofuran for verification. Density functional theory was used to optimize the structure of the hydrogen bond and π−π stacking formed by the co-crystal of FBP and 2-OHBZA. The assay results of the co-crystals of FBP-2-OHBZA are in good agreement with the calculated values reported.

Keywords